Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Wiseman

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Drugs & Aging|September 26, 1997
VorozoleL R Wiseman, C M Spencer
Drugs|November 7, 1999
ExemestaneL J Scott, L R Wiseman
Drugs|April 3, 1999
BasiliximabS V Onrust, L R Wiseman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
TrastuzumabC M Perry, L R Wiseman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 1997
Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disordersC M Spencer, L R Wiseman
Drugs|November 7, 1998
Topotecan. A review of its potential in advanced ovarian cancerR N Brogden, L R Wiseman
Drugs|August 10, 1999
Terbinafine. An update of its use in superficial mycosesK J McClellan, L R Wiseman, A Markham
Drugs|April 8, 1998
CerivastatinK J McClellan, L R Wiseman, D McTavish
Drugs|November 21, 2000
Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignanciesC R Culy, D Clemett, L R Wiseman
Drugs|September 1, 1992
Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular diseaseL R Wiseman, A Fitton, M M Buckley
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Drugs & Aging|September 26, 1997
VorozoleL R Wiseman, C M Spencer
Drugs|November 7, 1999
ExemestaneL J Scott, L R Wiseman
Drugs|April 3, 1999
BasiliximabS V Onrust, L R Wiseman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
TrastuzumabC M Perry, L R Wiseman
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 1997
Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disordersC M Spencer, L R Wiseman
Drugs|November 7, 1998
Topotecan. A review of its potential in advanced ovarian cancerR N Brogden, L R Wiseman
Drugs|August 10, 1999
Terbinafine. An update of its use in superficial mycosesK J McClellan, L R Wiseman, A Markham
Drugs|April 8, 1998
CerivastatinK J McClellan, L R Wiseman, D McTavish
Drugs|November 21, 2000
Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignanciesC R Culy, D Clemett, L R Wiseman
Drugs|September 1, 1992
Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular diseaseL R Wiseman, A Fitton, M M Buckley
Pageof 5